key: cord-0737681-a8jejqj9
authors: Srivasrav, A. K.; Stollenwerk, N.; Bidaurrazaga Van-Dierdonck, J.; Mar, J.; Ibarrondo, O.; Aguiar, M.
title: Modeling the initial phase of COVID-19 epidemic: The role of age and disease severity in the Basque Country, Spain
date: 2022-04-20
journal: nan
DOI: 10.1101/2022.04.18.22273983
sha: 58498c8bab792d54ef2b8c138587a7b5f8f2139d
doc_id: 737681
cord_uid: a8jejqj9

Declared a pandemic by the World Health Organization (WHO), COVID-19 has spread rapidly around the globe. With eventually substantial global underestimation of infection, by the end of March 2022, more than 470 million cases were confirmed, counting more than 6.1 million deaths worldwide. COVID-19 symptoms range from mild (or no) symptoms to severe illness, with disease severity and death occurring according to a hierarchy of risks, with age and pre-existing health conditions enhancing risks of disease severity. In order to understand the dynamics of disease severity during the initial phase of the pandemic, we propose a modeling framework stratifying the studied population into two groups, older and younger, assuming different risks for severe disease manifestation. The deterministic and the stochastic models are parametrized using epidemiologicaldata for the Basque Country population referring to confirmed cases, hospitalizations and deaths, from February to the end of March 2020. Using similar parameter values, both models were able to describe well the existing data. A detailed sensitivity analysis was performed to identify the key parameters influencing the transmission dynamics of COVID-19 in the population. We observed that the population younger than 60 years old of age would contribute more to the overall force of infection than the older population, as opposed to the already existing age-structured models, opening new ways to understand the effect of population age on disease severity during the COVID-19 pandemic. With mild/asymptomatic cases significantly influencing the disease spreading and control, our findings support the vaccination strategy prioritising the most vulnerable individuals to reduce hospitalization and deaths, as well as the non-pharmaceutical intervention measures to reduce disease transmission.

More than two years have passed since COVID-19, a severe respiratory syndrome 2 caused by a new coronavirus, was identified by the Chinese authorities in January 3 2020 [1] . Declared a global pandemic by the World Health Organization (WHO) in 4 March 2020 [2] , COVID-19 symptoms range from asymptomatic/mild to severe illness, 5 with age and pre-existing health conditions increasing the likelihood of disease 6 severity [3] . Vaccines against COVID-19 have been developed in record time and are 7 now globally distributed [4, 5] . Although these vaccines are remarkably effective against 8 severe disease, the so called sterilizing immunity, occurring when vaccinated individuals 9 cannot transmit the virus, is still being evaluated. 10 Based on previous research experiences applied to other infectious diseases [6] [7] [8] [9] [10] [11] [12] [13] [14] , 11 and more recently applied to COVID-19 dynamics [15] [16] [17] [18] [19] , the role of asymptomatic 12 infections have been studied, showing that vaccine performance is driven by the ability 13 of asymptomatic or mild disease cases transmitting the virus, with an eventual increase 14 on the number of overall infections in a population [20, 21] . 15 As an example of the pandemic's impact in Europe, Spain has reported, by the end 16 of March 2022, more than 11.5 million COVID-19 cases and over 100 thousand 17 deaths [22, 23] , with a significantly higher mortality rate for individuals older than 65 18 years of age [24, 25] , in agreement with what was also observed in different European 19 countries [26]. 20 As the COVID-19 pandemic progressed, task forces have been created to assist 21 public health managers and governments during the COVID-19 crisis, and research on 22 mathematical modeling became critical to understand the epidemiological dynamics of 23 COVID-19. Modeling studies to evaluate COVID-19 dynamics worldwide have been 24 widely published. Using both, deterministic and stochastic approaches, models were 25 developed to investigate disease spreading in different epidemiological contexts as well 26 as the impact of the control measures so far implemented. Using the existing empirical 27 data, these models have given insights on disease transmission rates, the effect of 28 quarantine or use of facial masks, for example, with modeling assumptions statistically 29 tested with the available empirical data [27] [28] [29] [30] .

ways to understand the effect of age on disease severity during the pandemic. In terms 53 of policy implications, our findings support the vaccination strategy prioritising the 54 most vulnerable individuals [16] , particularly to reduce hospitalization and deaths [21] , 55 as well as the non-pharmaceutical intervention measures that are still advised by the 56 WHO to reduce disease transmission. 57 This paper is organized as follows. Section 1 presents the deterministic and the 58 stochastic models formulation, followed by the model analysis. Section 2 is dedicated to 59 data analysis, model calibration and parameter estimation. In Section 3 we present the 60 models simulation and results, including a detailed sensitivity analysis for the 61 parameters involved in reproduction number. We conclude this work with a discussion 62 on the results obtained by both modeling approaches. 63 1 Materials and methods 64 Using age stratified data for COVID-19 incidences for tested positive cases, 65 hospitalizations and deaths in the the Basque Country, this work is applied to the initial 66 phase of the pandemic. Using statistical tools to analyse these data, we define as severe 67 cases all hospitalized individuals, including the intensive care unit (ICU) admissions, for 68 young (H 1 ) and old patients (H 2 ), reported from February 15 to March 25, 2020 . It is 69 important to mention that at the beginning of the pandemic, due to the testing capacity 70 limitations, only patients with severe symptoms were tested using the PCR (Polymerase 71 Chain Reaction) method. 72 

This model framework is a refinement of the model proposed by Srivastav et al. [27, 35] . 74 For both age groups, young and old, susceptible individuals become exposed and 75 infected E i , developing either mild/asymptomatic A i or severe/hospitalized H i disease. 76 While mild/asymptomatic infections are assumed to recover, severe disease might evolve 77 to death D. The parameter ϕ differentiates the disease transmission between 78 hospitalized (H 1 + H 2 ) and mild/asymptomatic infections (A 1 + A 2 ), and the parameter 79 ϵ is introduced to differentiate the infectivity of asymptomatic young individuals (A 1 ) 80 with respect to the baseline infectivity for the elderly individuals A 2 (t) in the Basque 81 Country population of N = 2.6 million individuals. 82 The seriousness of symptoms from viral infections is often correlated with the 83 amount of the virus in the body [36, 37] . Justified by the differences observed in viral 84 load during the COVID-19 infection, lower for mild/asymptomatic and higher for 85 severe/hospitalized cases, we assume ϵ < 1, indicating that young individuals have 86 smaller infectivity than the elderly individuals. This assumption relies on the 87 epidemiological observation of young individuals developing mild or no symptoms during 88 the infection as opposed to the observation of severe symptoms occurring mostly in 89 older ages, shaping the disease transmissibility pattern in a population. The parameter 90 ϕ is a scaling factor used to differentiate the infectivity of mild/asymptomatic infections 91 (ϕβ) with respect to the baseline infectivity of severe/hospitalized cases (β). The value 92 of ϕ can be tuned to reflect different situations: a value of ϕ < 1 reflects the fact that 93 severe cases have larger infectivity than mild cases (e.g., due to enhanced coughing and 94 sneezing), while ϕ > 1 indicates that asymptomatic individuals and mild cases 95 contribute more to the spread of the infection (e.g., due to their higher mobility and 96 possibility of interaction) than the severe cases which are more likely to be detected and 97 isolated [15] . Here, we assume ϕ > 1, with asymptomatic individuals contributing more 98 to the force of infection than the hospitalized individuals [38, 39] .

The total population N is divided into ten compartments, stratified into two age 100 groups, young and old. Susceptible S 1 (t) and S 2 (t), Exposed E 1 (t) and E 2 (t), 101 mild/Asymptomatic A 1 (t) and A 2 (t) or severe/Hospitalized H 1 (t) and H 2 (t) cases.

Labels 1 and 2 refers to the young and to the old age populations respectively. Two 103 extra classes to accommodate individuals from both age-groups are also considered. The 104 deceased class D(t), for those who died from COVID-19, and finally the recovered class 105 R(t), counting all individuals recovered from the disease.

For the mathematical modelling framework development, we make the following 107 assumptions: 108 1. The total population N is constant. 109 2. The susceptible young individuals S 1 become exposed to the infection E 1 by 110 contacting infectious individuals A 1 , A 2 and H 1 , H 2 at rates ϕβ and β, respectively. 111 3. The susceptible old individuals S 2 become exposed to the infection E 2 by 112 contacting infectious individuals A 1 , A 2 and H 1 , H 2 at rates ϕβ and β, respectively. 4. With i = 1, 2, for young and old respectively, exposed individuals E i will develop 114 mild/asymptomatic infection A i with rate aη i while the remaining individuals 115 developing severe symptoms will be admitted to a hospital facility H i with rate

(1 − a)η i . 117 5. While young and old asymptomatic individuals recover from COVID-19 infection 118 (R) with rate α 1 and α 3 respectively, hospitalized young individuals will recover with 119 rate α 2 while hospitalized old individuals will recover with rate α 4 . Young and old 120 hospitalized individuals will eventually die (D) with rate δ 1 and δ 2 respectively.

The flow diagram for the disease related stages of our proposed model is shown in 122 Figure 1 , which translates into the following ODE system describing the temporal 123 evolution of the number of individuals in each of the model compartments:

1.2 Existence of equilibrium points and the basic reproduction 125 number (R 0 )

While the disease-free equilibrium of the system is given by

, disease related stages are shown in orange color for young population and in light green for the old population. Deceased and recovered population include both age groups and are shown in black and purple, respectively. : recovery rate of asymptomatic young individuals α 3 : recovery rate of asymptomatic old individuals α 2 : recovery rate of hospitalized young individuals α 4 : recovery rate of asymptomatic old individuals a : Fraction of exposed population developing mild/asymptomatic disease (1 − a)

: Fraction of exposed population developing severe/hospitalized disease the basic reproduction number R 0 can be found by using the next generation matrix 129 method [40] , and is given by: . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 20, 2022 

The quantity R 1 = βS 0

is defined for the young group population 131 and the quantity R 2 = βS 0

is defined for the old group population. 132

The quantity R 0 = R 1 + R 2 is the average number of secondary cases produced in a 133 completely susceptible population by an index case, during the infectious period.

The calculation of the basic reproduction number R 0 is shown in the Appendix of 135 this manuscript. We can summarize our findings in the following theorems.

Theorem 1.1 If R 0 < 1, the disease-free equilibrium 137 E 0 = (N 0 1 , 0, 0, 0, N 0 2 , 0, 0, 0, 0, 0, 0) of the system (1) is locally asymptotically stable, and 138 if R 0 > 1, the disease-free equilibrium E 0 is unstable.

Next, we prove globally asymptotically stability of disease-free equilibrium. (1) is globally asymptotically stable 142 whenever eigenvalue of the matrix F − V are having negative real parts, and if R 0 > 1, 143 the disease-free equilibrium E 0 is unstable.

The proof of the global stability can be found in the Appendix of this manuscript. The derivation of the stochastic model and its analysis are important when populations 149 are small, and hence with the dynamics being severely affected by small changes in the 150 parameter values. Thus, for the initial phase of the COVID-19 outbreak, the stochastic 151 model setup is the most appropriate modeling approach to be used for a local 152 epidemiological evaluation.

The derivation of a stochastic differential equation (SDE) model is a diffusion 154 approximation from the underlying state discrete Markov process [17, [41] [42] [43] [44] [45] . Let 155 X(t) = (X 1 (t), X 2 (t), X 3 (t), X 4 (t), X 5 (t), X 6 (t), X 7 (t), X ( 8), X 9 (t), X 10 (t)) T be a continuous random variable for

where T denotes transpose of the matrix. Further, let Table 2 , followed by the full SDE . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 20, 2022. ; Table 2 . Possible changes of states and their probabilities.

Probability of state change (∆X) 1 = (−1, 1, 0, 0, 0, 0, 0, 0, 0, 0) T P 1 = βX 1 [ϕ(X 3 + ϵX 7 ) + (X 4 + X 8 )]∆t + O(∆t) Change when young susceptible meet infected individuals and move to the young exposed class (∆X) 2 = (0, −1, 1, 0, 0, 0, 0, 0, 0, 0) T P 2 = aη 1 X 2 ∆t + O(∆t) Change when fraction of young exposed become infectious and move to the young asymptomatic infected class (∆X) 3 = (0, −1, 0, 1, 0, 0, 0, 0, 0, 0) T P 3 = (1 − a)η 1 X 2 ∆t + O(∆t) Change when fraction of young exposed become infectious and move to the young hospitalized class 

The detailed derivation of the stochastic model can be found in the Appendices of this 162 manuscript.

April 14, 2022 7/30 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 20, 2022 stratification was decided after a careful data inspection and data fitting, followed by 171 the parameter estimation. 172 We use the epidemiological data referring to the cumulative incidences of confirmed 173 positive cases, hospitalizations, including ICU admissions, and deceased cases 174 distributed by age groups available for the initial phase of the COVID-19 in the Basque 175 Country, from February 15 to to March 25, 2020, as shown in Table 3 .

Note that during this period, testing capacity was limited and therefore the positive 177 detected cases were restricted to symptomatic individuals and eventually to their close 178 contacts during the process tracing and testing strategy. Using MATLAB software, parameter estimation was performed using nonlinear least square method [46] . In detail, we search for the set of parametersΘ = (θ 1 ,θ 2 ,θ 3 . . .θ n ) that minimizes the sum of squared differences between the observed data y ti = (y t1 , y t2 . . . y tn ) and the corresponding model solution denoted by (f (t i , Θ)

The Root Mean Square Error (RMSE) values for the deterministic and stochastic models are calculate using the following formula,

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 20, 2022. ;  where t i are the time points at which the time series data are observed, and n is the 181 number of data points available for parameter inference. Hence, the model solution 182 f (t i , Θ) yields the best-fit to the time series data y ti . During the initial phase of the pandemic, a strong correlation of positive cases and 186 severe disease leading to hospitalizations is observed, see y-axis of Fig. 2 a) and 2b).

Increased age appears to be a strong risk factor for developing severe illness with 188 COVID-19 infections, however, by looking at the raw data referring to the hospital 189 admissions, this consideration is not very clear, with similar high hospitalization rates 190 for individuals younger than 50 years of age and individuals older than 70 years of age. 191 Nevertheless, when looking at the deceased cases, it is indeed observed that older adults 192 have higher risk of severe outcomes. With potential underlying health conditions [3] , . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 20, 2022. individuals in the population older than 40 years of age. Models are calibrated with the 200 data and the parameters reflecting the differences in disease transmission by age group 201 is estimated. The available data referring to cumulative hospital admission cases, for the young and the old age groups, are matched with both models, deterministic and stochastic. Figure 3 shows the models fitting to the empirical raw data. In this data matching scenario, the RMSE values for the deterministic and stochastic models are 0.55 and 0.47 respectively, indicating that the stochastic modeling approach explains better the existing data. The scaling factor parameter used to differentiate the infectivity of severe/hospitalized cases ϕ, and scaling factor parameter used to differentiate the infectivity of young and elderly mild/asymptomatic cases ϵ, were estimated to be ϕ = 1.2, ϵ = 0.25 for the young group, and ϕ = 1.55, ϵ = 0.4

for the old group. The other parameter values are fixed as suggested in [17] . Referring 203 to the raw data, the used parameter values for the data fitting are listed in Table 4 .

April 14, 2022 10/30 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 20, 2022 The normalized raw data relative to the population size for each age class in the Basque 206 Country is shown Table 3 , with its visual age distribution shown in Fig. 4 . Similarly to what was observed with the raw data, positive cases are increasing with 208 age. The large majority of the deceased cases have been reported for the 80 years and 209 April 14, 2022 11/30 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 20, 2022. ;  older population group, confirming the strong correlation of severe disease outcome and 210 age. Nevertheless, the normalization of the raw data shows clearer an increase of 211 hospitalization rates for older age classes, allowing us to modify our modeling age 212 stratification definition for young and old groups. 213 We summarize the distribution of disease cases using box plots to represent the 214 deviation in the reported cases by age, see Fig. 5 , with the median being the measure of 215 central tendency of the underlying distribution of the data as shown on Table 3 . suggesting that they are more likely to develop symptoms than individuals at younger 218 ages. In respect to the hospitalizations, see Fig. 5 ), the median values are similar for 219 the individuals older than 50 years of age, suggesting that infections within these age 220 groups are likely to be more severe requiring hospitalizations than for the younger ages, 221 with individuals older than 80 years of age more likely to die from COVID-19 infection 222 than any other age class, see Fig. 5 c) . For these data, the age distribution assumption 223 is now modified, considering individuals between 0-69 years of age as part of the young 224 April 14, 2022 12/30 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 20, 2022. ; https://doi.org/10.1101/2022.04.18.22273983 doi: medRxiv preprint group and individuals older than 70 years of age as part of the old age group. Table 4 . This parameter set will be used in the 

In order to detect which are the parameters with higher impact on the R 0 measure, 242 with effects to increase or to decrease its value and consequently to define which 243 parameters are to be targeted by intervention measures, we use the the normalized 244 forward sensitivity method index of a variable to a parameter [47] . The normalized 245 forward sensitivity index of R 0 is defined using partial derivatives, showing the variation 246 of the variable with respect to a given parameter p, as follows is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 20, 2022. ; https://doi.org/10.1101/2022.04.18.22273983 doi: medRxiv preprint While the magnitude of the R 0 measure increases as the values of β, a, ϕ, and ϵ 249 parameters increase (positive indices), an inverse relation with the R 0 value is observed 250 for the δ 1 , α 1 , α 2 , α 3 , α 4 , and δ 2 parameters, with negative indices, i.e., as the 251 parameter values increase, the magnitude of R 0 decreases. The sensitivity index of R 0 252 for the parameter β is 1, meaning that R 0 increases or decreases with the same 253 percentage as the parameter β varies, see Figure 7 . Complementary to the forward sensitivity method index analysis above, we use the 255 spline regression method to fit 10000 points for a range of each parameter value. The 256 quantification of the parameter variation effect on the R 0 value is shown in Fig. 8,   257 confirming that the increase of the transmission rate β, the fraction of asymptomatic In this section, we explore different parameter combinations for the disease infectivity 262 factors ϕ and ϵ and for the disease induced mortality rate δ that are able to explain the 263 exponential phase of the COVID-19 epidemic in the Basque Country. For both, the 264 deterministic and stochastic models, the assumed biological parameters for COVID-19 265 dynamics were estimated for the normalized data, see Table 4 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 20, 2022. ;  disease severity dynamics during the initial phase of the pandemics, numerical 271 simulations are performed to describe the available data in the Basque Country, from 272 February 15 to March 25, 2020, see Fig. 10 (a) . This is a dynamical work. While the 273 present analysis focus on the introductory phase of the pathogen in the Basque Country, 274 the evaluation of the effect of the imposed control measures will be carried out later.

Epidemiological data used in this study are provided by the Basque Health 276 Department and the Basque Health Service (Osakidetza), continually collected with 277 specific inclusion and exclusion criteria. We use the following incidence and cumulative 278 data for RT-PCR (reverse transcriptase-polymerase chain reaction), see Fig. 9 . While 279 the incidence data are shown in Fig. 9 (a) , the cumulative data used here refer to the 280 overall hospital admissions, including the ICU cases, are shown in orange and the 281 decease cases in black.

Within the timeline of first wave of the pandemic in the Basque Country, the black 283 line shows the date of the partial lockdown implementation, followed by the full 284 lockdown, see red line. The light blue line shows the last data point used in this study, 285 March 25, 2020, ten days after the partial lockdown was implemented, when the 286 exponential growth of disease cases decelerates into a growth close to zero towards a 287 linear phase [19] . is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 20, 2022 disease with an extremely high transmission rate were gradually adjusted overtime. It is 320 now accepted that COVID-19 disease severity and death occur according to a hierarchy 321 of risks, with age and pre-existing health conditions enhancing risks of disease severity. 322 In this paper, a mathematical model framework for COVID-19 transmission is Further, the deterministic model was extended to its stochastic counterpart. The can be found in the Appendices.

Both models were able to fit well the empirical data using similar parameter value 338 range, with the stochastic model always presenting a better result. A detailed sensitivity 339 analysis was performed allowing us to identify the key parameters affecting the disease 340 dynamics.

An exploratory analysis to understand the impact of those key parameters on disease 342 severity dynamics during the initial phase of the pandemics, from February 15 to March 343 25, 2020, was performed. Numerical simulations have demonstrated that differences in 344 infectivity from severe/hospitalized cases and mild/asymptomatic cases are the most 345 important factors influencing the disease spreading in the population and without any 346 control measure, the epidemic would have followed its course with a massive number of 347 hospitalizations and deaths within the first 100 days of the pandemic.

These results are of use to guide public health authorities on disease control. The 349 sensitivity analysis results shown in Fig. 7 and Fig. 8 give insights on how to control the 350 disease outbreak, suggesting possible ways of action for an effective containment of the 351 disease transmission towards its elimination by limiting the increase of parameters with 352 positive indices. On the other hand, by increasing the parameters with positive indices, 353 such as providing treatment for a fast recovery or decreasing mortality, for example.

The numerical simulations have shown that without the lockdown, disease cases 355 would increase continuously with severe cases eventually reaching its maximum numbers 356 towards the herd immunity scenario, i.e, when a large portion of the population become 357 immune to the disease. This behaviour was observed to affect the old group population 358 much faster than the young population. Minimizing the scaling transmission factors, ϕ 359 and ϵ, via social distancing or vaccination, for example, would significantly reduce the 360 disease burden in the population. Therefore, in terms of policy implications, our findings 361 support the vaccination strategy prioritising the most vulnerable individuals to reduce 362 hospitalization and deaths, as well as the non-pharmaceutical intervention measures, 363 that are still advised by the public health authorities, to reduce disease transmission. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 20, 2022. ;  This is a dynamical work. While the present analysis has focused on the initial 365 phase of the COVID-19 epidemic in the Basque Country, it is important to mention 366 that the evaluation of the effect of the imposed lockdown and other control measures is 367 ongoing. As continuation of this work, the models are under refinement, using this 368 framework as baseline to describe the progression of COVID-19 epidemics in the Basque 369 Country and to understand the impact of lockdown implementation and the increased 370 of testing capacity over time. As our model is able to describe the available data, see 371 Fig. 12 , we will be also able to measure the impact of mild/asymptomatic cases on 372 disease spreading and control, including non-sterilizing vaccine performance [21] . The simulation plotted as red line includes a control function (β(t) = β 0 σ − (x(t)) + β 1 σ + (x(t)), with σ(x) = 1 1+e −x , see [17] ) which is able to describe the empirical data, while the green line shows the solution without any control. The black line shows the last data point used in this study, March 25, 2020, ten days after the partial lockdown was implemented. By that date, the exponential growth of disease cases decelerates into a growth close to zero towards a linear phase. The full lockdown started on March 31, 2020 (black dashed line).

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 20, 2022. ; https://doi.org/10.1101/2022.04.18.22273983 doi: medRxiv preprint Supporting information 374 S1 Appendix. Computation of the basic reproduction number R 0 : We find 375 the basic reproduction number R 0 by following the next generation matrix method [40] . 376 We consider (E 1 , A 1 , H 1 , E 2 , A 2 , H 2 ) for the vector F and V as follows:

and 

and V is the Jacobian matrix of V at E 0 hence

Then calculated matrix F V −1 and simplifying, |λI − F V −1 | = 0 gives the characteristics equation as follows:

Where a 1 = 1, a 2 = (a 11 + a 44 ), a 3 = a 11 a 44 − a 14 a 41 and So the basic reproduction number (R 0 ) is the positive root of the above quadratic and is 381 given by:

Proof of theorem 0.2:

Proof: To prove the global stability of disease free equilibrium, we are using the theorem by Castillo-Chavez et. al. [48] , and re-writing the equations for the exposed, infected and hospitalization compartments in (1) we get

If all the eigenvalues of the matrix F − V have negative real parts, the system is stable for R 0 < 1. So, By the comparison theorem, it follows that

E 0 is globally asymptotically stable for R 0 < 1. Let us consider the case when one uninfected human is infected by a covid virus. In that 388 case, the state change ∆X is denoted by ∆X = (−1, 1, 0) and its probability is given by 389

One can easily determine the expectation change E(∆X) and its covariance matrix . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 20, 2022 

Here, it can be noted that the expectation vector and the function f are in the same 393 form as those in the deterministic system. Since the covariance matrix is given times ∆t by neglecting the term of (∆t) 2 such that

where the above diffusion matrix is symmetric, positive-definite and each component of 398 this 3 × 3 diffusion matrix is given by 

In view of the above facts, we construct the stochastic differential equation We follow above Method to construct the stochastic process: Let us consider the 409 case when one uninfected human is infected by a covid virus. In that case, the state 410 change ∆X is denoted by ∆X = (−1, 1, 0, 0, 0, 0, 0, 0, 0, 0) and its probability is given by 411 prob(∆X 1 , ∆X 2 , ∆X 3 , ∆X 4 , ∆X 5 , ∆X 6 , ∆X 7 , ∆X 8 , ∆X 9 , ∆X 10 ) = prob((−1, 1, 0, 0, 0, 0, 0, 0, 0, 0)|(X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 , X 8 , X 9 , X 10 )) = P 1 = βX 1 X 2 ∆t + O(t).

One can easily determine the expectation change E(∆X) and its covariance matrix 412 V (∆X) associated with ∆X by neglecting the terms higher than O(∆t). The 413 expectation of ∆X is given by

= f (X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 , X 8 , X 9 , X 10 )∆t.

Here, it can be noted that the expectation vector and the function f are in the same 415 form as those in deterministic system (1) . Since the covariance matrix 

where the above diffusion matrix is symmetric, positive-definite and each component of 420 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 20, 2022. ;  this 10 × 10 diffusion matrix are given by 421 V 11 = P 1 = βX 1 [ϕ{X 3 + ϵX 7 } + (X 4 + X 8 )], V 12 = V 21 = −P 1 = −βX 1 [ϕ{X 3 + ϵX 7 } + (X 4 + X 8 )], V 22 = P 1 + P 2 + P 3 = βX 1 [ϕ{X 3 + ϵX 7 } + (X 4 + X 8 )] + aη 1 X 2 + (1 − a)η 1 X 2 V 23 = V 32 = −P 2 = −aη 1 X 2 , V 24 = V 42 = −P 3 = −(1 − a)η 1 X 2 , V 33 = P 2 + P 4 = aη 1 X 2 + α 1 X 3 , V 39 = V 93 = −P 4 = −α 1 X 3 , V 44 = P 3 + P 5 + P 6 = (1 − a)η 1 X 2 + δ 1 X 4 + α 2 X 4 , V 4,10 = V 10,4 = −P 5 = −δ 1 X 4 , V 55 = P 7 = βX 5 [ϕ{X 3 + ϵX 7 } + (X 4 + X 8 )], V 56 = V 65 = −P 7 = −βX 5 [ϕ{X 3 + ϵX 7 } + (X 4 + X 8 )], V 66 = P 7 + P 8 + P 9 = βX 5 [ϕ{X 3 + ϵX 7 } + (X 4 + X 8 )] + aη 2 X 6 + (1 − a)η 2 X 6 , V 67 = V 76 = −P 8 = −aη 2 X 6 , V 68 = V 86 = −P 9 = −(1 − a)η 2 X 6 , V 77 = P 8 + P 10 = aη 2 X 6 + α 3 X 7 , V 79 = V 97 = −P 10 = α 3 X 7 V 88 = P 9 + P 11 + P 12 = (1 − a)η 2 X 6 + δ 2 X 8 + α 4 X 8 , V 89 = V 98 = −P 12 = −α 4 X 8 , V 8,10 = V 10,8 = −P 11 = δ 2 X 8 , V 99 = P 4 + P 6 + P 10 + P 12 = α 1 X 3 + α 2 X 4 + α 3 X 7 + α 4 X 8 , V 10,10 = P 5 + P 11 = δ 1 X 4 + δ 2 X 8 . Then, the Ito stochastic differential model has the form, 425 d(X(t)) = f (X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 , X 8 , X 9 , X 10 )dt + M · dW (t) with initial condition 426 X(0) = (X 1 (0), X 2 (0), X 3 (0), X 4 (0), X 5 (0), X 6 (0), X 7 (0), X 8 (0), X 9 (0), X 10 (0)) T and a Wiener process, are along with the standard deviation σ 427 W (t) = (W1(t), W2(t), W3(t), W4(t), W5(t), W6(t), W7(t), W8(t), W9(t), W10(t), W11(t), W12(t)) T April 14, 2022 26/30 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 20, 2022 

World Health Organization. Coronavirus disease (COVID-19) pandemic

World Health Organization. WHO announces COVID-19 outbreak a pandemic

Condition-specific mortality risk can explain differences in COVID-19 case fatality ratios around the globe

Safe COVID-19 vaccines

The Epidemiological SHARUCD Model Dashboard

Bayesian estimation of vaccine efficacy

Modeling the impact of the newly licensed dengue vaccine in endemic countries

The risks behind Dengvaxia recommendation. The Lancet Infectious Diseases

Consider stopping dengvaxia administration without immunological screening

Dengvaxia Efficacy Dependency on Serostatus: A Closer Look at More Recent Data

Dengvaxia: age as surrogate for serostatus. The Lancet Infectious Diseases

Dengue vaccination: a more ethical approach is needed

Ethics of a partially effective dengue vaccine: Lessons from the Philippines

The Impact of Serotype Cross-Protection on Vaccine Trials: DENVax as a Case Study

SHAR and effective SIR models: from dengue fever toy models to a COVID-19 fully parametrized SHARUCD framework

A multiscale network-based model of contagion dynamics: heterogeneity, spatial distancing and vaccination

Modelling COVID 19 in the Basque Country from introduction to control measure response

Critical fluctuations in epidemic models explain COVID-19 post-lockdown dynamics

Reproduction ratio and growth rates: measures for an unfolding pandemic

Modeling COVID-19 vaccine efficacy and coverage towards herd-immunity in the Basque Country

The role of mild and asymptomatic infections on COVID-19 vaccines performance: a modeling study (In press)

Coronavirus Statistics. Coronavirus cases in Spain

COVID-19) in Spain as of

COVID-19 mortality risk for older men and women

Institut national d'études démographiques (INED). The Demography of COVID-19 Deaths: data and metadata by country

Modeling and Optimal Control Analysis of COVID-19: Case Studies from Italy and Spain

A statistical analysis of the novel coronavirus (COVID-19) in Italy and Spain

A mathematical model for the impacts of face mask, hospitalization and quarantine on the dynamics of COVID-19 in India: deterministic vs. stochastic

Deterministic and stochastic models for the epidemic dynamics of COVID-19 in Wuhan

Quantifying the effects of non-pharmaceutical and pharmaceutical interventions against COVID-19 epidemic in the Republic of Korea: Mathematical model-based approach considering age groups and the Delta variant, medRxiv

Two-Age-Structured COVID-1 Epidemic Model:Estimation of Virulence Parameters to Interpret Effects of National and Regional Feedback Interventions and Vaccination

Age-stratified discrete compartment model of the COVID-19 epidemic with application to Switzerland

Age-Stratified Infection Probabilities Combined With a Quarantine-Modified Model for COVID-19 Needs Assessments: Model Development Study

Deterministic and Stochastic Dynamics of COVID-19: The Case Study of Italy and Spain

Viral dynamics in mild and severe cases of COVID-19

SARS-CoV-2 viral load is associated with increased disease severity and mortality

Prevalence of Asymptomatic SARS-CoV-2 Infection

SARS-CoV-2 Trans-mission From People Without COVID-19 Symptoms

Reproduction numbers and subthreshold endemic equilibria for compartmental models of disease transmission

Population Biology and Criticality: From Critical Birth-Death Processes to Self-Organized Criticality in Mutation Pathogen Systems

Construction of equivalent stochastic differential equation models

Stochastic Processes in Physics and Chemistry

Handbook of Stochastic Methods

Stochastic models for virus and immune system dynamics

Parameter Estimation and Nonlinear Least-Squares Methods

Sensitivity Analysis of Parameters in a Competition 249

Global stability for the SEIR model in epidemiology

Following [45] , we construct a matrix M such that Ω = M M T , where M is a 10 × 12 422 matrix given as